baber/WOPTO huggingface dataset:
Patent AU-2001252603-B2 (AU)
Title: Liposomes containing hydrophobic iodo compound
Inventor: KITAGUCHI HIROSHI
IPC: A61K49/04
Filed: 2001-04-26
Granted: 2005-10-13
Abstract: A liposome containing a hydrophobic iodine compound such as a 1,3,5-triiodobenzene derivative having at least one substituent containing 18 or more carbon atoms as a membrane component, and an X-ray contrast medium containing the liposome for use in radiography of a vascular disease and the like.
Patent AU-2001268133-B2 (AU)
Title: Alpha-fetoprotein peptides and uses thereof
Inventor: MESFIN FASSIL B
IPC: C07K7/06
Filed: 2001-06-02
Granted: 2008-05-15
Abstract: The subject invention addresses the need for methods of treatment and prevention of breast cancer, and other cancers, by providing a peptide of eight to twenty amino acids in length which comprises a hydrophilic analog of an alpha-fetoprotein peptide having SEQ ID NO:6: EMTPVNPG. The peptides may be linear, but are preferably cyclic. The peptides may be provided as dimers or other multimers. A composition comprising the peptide, and antibody that specifically binds to the peptide, a method of reducing estrogen-stimulated growth of cells using the peptides, as well as a method of treating or preventing cancer, such as breast cancer, are also provided. The treatment or prevention method can include the use of tamoxifen therapy in combination with the peptide therapy.
Patent AU-2001278045-B2 (AU)
Title: Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
Inventor: SCHUH JOSEPH R
IPC: A61P3/00
Filed: 2001-07-27
Granted: 2006-08-03
Abstract: A combination therapy comprising a therapeutically-effective amount of an epoxy-steroidal aldosterone receptor antagonist and a therapeutically-effective amount of a calcium channel blocker is described for treatment of circulatory disorders, including cardiovascular disorders such as hypertension, congestive heart failure, cirrhosis and ascites. Preferred calcium channel blockers are those compounds having high potency and bioavailability. Preferred epoxy-steroidal aldosterone receptor antagonists are 2O-spiroxane steroidal compounds characterized by the presence of a 9alpha,11alpha-substituted epoxy moiety. A preferred combination therapy includes the calcium channel blocker verapamil HC1 (Benzenacetonitrile, (±) -alpha[3[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)hydrochloride) and the aldosterone receptor antagonist epoxymexrenone.
Patent AU-2001284483-B2 (AU)
Title: Remedies for heart failure
Inventor: FURUYA MAYUMI
IPC: C07K14/47
Filed: 2001-09-07
Granted: 2006-08-10
Abstract: The present invention provides methods for screening drugs inhibiting the expression of OSF-2 gene or the production or function of the protein encoded thereby and therapeutic agents for heart failure having such effects. Useful methods for diagnosing heart failure can be provided by monitoring the expression or variation of said gene or the production of the protein encoded thereby. The present invention also provides transgenic animals with forced expression of OSF-2 gene and methods for studying changes in gene expression or protein production or the functions of various genes or proteins with the progress of the pathology of heart failure using them and novel therapeutic agents for heart failure.
Patent AU-2002218242-B2 (AU)
Title: Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
Inventor: MULLER ADAM
IPC: B01J3/00
Filed: 2001-10-16
Granted: 2006-04-06
Abstract: The invention relates to a method for producing an extract from cannabis plant matter, containing tetrahydrocannabinol, cannabidiol and optionally the carboxylic acids thereof. According to said method, the dried plant matter is ground and subjected to a CO2 extraction and the primary extract obtained is separated. The invention method permits Δ8 or Δ9 tetrahydrocannabinol to be selectively obtained both from industrial hemp and from drug-producing hemp, optionally after dissolving the primary extract in ethanol, separating undesirable waxes and removing the solvent under reduced pressure.
Patent AU-2002228193-B2 (AU)
Title: Communication method and apparatus
Inventor: FEBVRE PAUL
IPC: H04L7/04
Filed: 2002-01-30
Granted: 2007-02-08
Abstract: A synchronisation pattern is encoded into a first encoded output and the data is encoded into a second encoded output. A frame is generated from the unencoded synchronisation pattern and the first and second encoded outputs. <IMAGE>
Patent AU-2002237699-B2 (AU)
Title: Human testis specific serine/threonine kinase
Inventor: HAO ZHONGLIN
IPC: G01N33/15
Filed: 2001-11-09
Granted: 2006-05-25
Abstract: The present invention relates to a family of testis specific kinases (the tssk family), nucleic acid sequences encoding those kinases and antibodies against the kinases. The invention is further directed to the use of thise kinases as targets for isolating specific inhibitors or anagonists of tssk kinase activity. Such inhibitors are anticipated to have use as contraceptive agents.
Patent AU-2002310255-B2 (AU)
Title: High temperature lubricant composition
Inventor: MCHENRY MICHAEL A
IPC: C10M135/18
Filed: 2002-05-31
Granted: 2008-02-07
Abstract: Improved synthetic lubricants based on a 100% polyol ester composition suitable for use in high temperature static chain oil applications is provided. The lubricant includes a base stock based on a polyol ester that is the reaction product of a neopentyl polyol including a major proportion of dipentaerythritol and a mixture of C5 to C12 carboxylic acids. The preferred carboxylic acid mixture includes heptanoic (C7) acid, caprylic/capric (C8-10) acid and isononanoic (3, 5, 5-trimethylhyxanoic acid (iso-C9). The polyol base stock is mixed with an additive package that includes a viscosity index improver (tackifier), antioxidants, extreme pressure/antiwear agents and a corrosion inhibitor. The additive package may be added in up to about 20 percent by weight of the lubricant to provide a viscosity of the lubricant at 40° C. of at least about 275 cSt and at 100° C. of no less than about 25.0 cSt.
Patent AU-2002316425-B2 (AU)
Title: A system and method for assessing urinary function
Inventor: NOHILLY MARTIN
IPC: A61B5/00
Filed: 2002-06-27
Granted: 2007-07-19
Abstract: A method is provided for assessing urinary function including removably coupling a first test module to a portable control device, selecting from a plurality of different tests a first test to assess urinary function, the selection being made based on first module identification information obtained by the control device from the test module, and performing the first test. The method may also include one or more of the steps of inserting an insert member coupled to the first test module at least partially into a patient's urinary tract, infusing fluid through the insert member into the urinary tract, and measuring pressure within the urinary tract as fluid is infused therein. The method may further include uncoupling the first test module from the portable control device, coupling a second test module to the portable control device, selecting a second test to assess urinary function based on second module identification information obtained by the control device from the second test module, and performing the second test.
Patent AU-2002336960-B2 (AU)
Title: Electropneumatic horn
Inventor: GIOVANNI CORRADO DI
IPC: G10K9/04
Filed: 2002-08-09
Granted: 2006-01-19
Abstract: An electropneumatic acoustic horn is disclosed, comprising an electric compressor unit for generating compressed air and a sound wave generator comprising at least an acoustic chamber associated to at least a volute wound acoustic duct adapted to propagate the produced sound to the outside. Air channelling means put the compressor unit in communication with each acoustic chamber. The compressor unit and the sound wave generator are mechanically connected in a removable way by fitting slidingly a collar.
Patent AU-2002364347-B2 (AU)
Title: Composite yarn, method for obtaining same and resulting textile structure
Inventor: CONESA ISABELLE
IPC: D02G3/40
Filed: 2002-12-27
Granted: 2008-01-31
Abstract: The invention concerns a composite yarn consisting of a continuous yarn, obtained by spinning fibers made of organic or inorganic material or natural fibers, and a polymer material. The invention is characterized in that the consecutive fibers said yarn are uniformly distributed in said polymer material such that each of said fibers is coated by said polymer material. The invention also concerns a method for making such a composite yarn and a textile structure obtainable from at least a composite yarn of the invention.
Patent AU-2002365868-B2 (AU)
Title: Implantable prosthetic valve
Inventor: BENICHU NETANEL
IPC: A61F2/82
Filed: 2002-10-11
Granted: 2008-07-03
Abstract: A valve prosthesis device suitable for implantation in body ducts, the device comprising an expandable support frame adapted to be initially crimped in a narrow configuration suitable for catheterization through the body duct to a target location and configured to be expanded to an expanded configuration in the target location, the support frame being provided with a plurality of longitudinally rigid support beams of fixed length; and a valve assembly comprising a flexible conduit having an inlet and an outlet, made of pliant material attached to the support beams providing collapsible slack portions of the conduit at the outlet, whereby when flow is allowed to pass through the valve prosthesis device from the inlet to the outlet the valve assembly is kept in an open position, whereas a reverse flow is prevented as the collapsible slack portions of the valve assembly collapse inwardly providing blockage to the reverse flow, characterized in that the support beams are provided with bores, the valve assembly is stitched to the support beams with thread or fiber through the bores and the outlet is tapered with respect to the inlet and the support frame at the outlet is wider in diameter than the pliant material forming the outlet.
Patent AU-2003202540-B2 (AU)
Title: Redundant transmission of protection commands between remote tripping devices
Inventor: KRANICH MATHIAS
IPC: H02H3/05
Filed: 2003-03-27
Granted: 2008-03-13
Abstract: A remote tripping device (1) transmits information representing protection command/rest signal in two time slots to a multiplexer (3) through an interface (2). The multiplexer transmits the received information in each time slot through associated transmission paths (4,5).  An Independent claim is also included for protection command redundant transmission device.
Patent AU-2003205121-B2 (AU)
Title: Antimicrobial urine collection system and methods of manufacturing the same
Inventor: LAMBERT JAMES M
IPC: A61F5/44
Filed: 2003-01-13
Granted: 2008-12-18
Abstract: An antimicrobial urine collection system comprising a urine collection bag and tubing each made from a polymer, wherein the polymer comprises therein from about 0.1 to 20 phr of an antimicrobial agent. The antimicrobial agent is preferably a phosphoric acid metal salt, preferably one in which zinc is the metal. The agent can be compounded into the polymer material for forming the system components.
Patent AU-2003217472-B2 (AU)
Title: Method for the creation of clearance holes
Inventor: CRIACCI MASSIMO
IPC: A47B87/02
Filed: 2003-03-07
Granted: 2007-05-17
Abstract: A method to join different materials through the creation of holes which allow entry of stay bolts is described. The method includes making slots on the plane of any material, the depth of these slots being equal to half the thickness of the plane, plus the length of the radius of the stay bolt or stud to be entered, plus a tolerance margin. The slots have a length as required by its end use and are made on two or more sides of the plane, in an alternate manner, so that the slot made on one side overlaps by a few millimeters the slot made on the opposite side creating a space for the passage of a stay bolt or stud that serves as the anchorage for the various pieces that make up an object to be realized.
Patent AU-2003223888-B2 (AU)
Title: Self-locking fastening device
Inventor: ESSER JOSEF
IPC: F16B39/24
Filed: 2003-03-19
Granted: 2008-05-08
Abstract: A self-locking fastening device which includes a screw or nut for fastening at least one first part to a second part and a shim ( 10 ) which is provided with a central borehole ( 11 ). The two surfaces of the shim ( 10 ) include rib profiles ( 12,14 ) which are fixed within or to the surfaces of the first part and the screw or nut no later than the time that the fastening device is tightened such that self-actuated unscrewing is prevented. The shim ( 10 ) is configured in a resilient manner such that the shim ( 10 ) can be compressed counter to the resilience thereof during tightening of the fastening device.
Patent AU-2003236760-B2 (AU)
Title: Protein extraction from canola oil seed meal
Inventor: MILANOVA RADKA
IPC: C07K1/34
Filed: 2003-06-19
Granted: 2009-01-22
Abstract: The recovery of protein from canola oil seed meal and other oil seed meals in the preparation of canola or other oil seed protein isolate is improved in comparison to conventional toasted meal by the use of a meal which has been air-desolventized at a temperature below about 50° C.
Patent AU-2004203102-B2 (AU)
Title: Human G Protein-Coupled Receptors
Inventor: LIAW CHEN W
IPC: C07D409/12
Filed: 2004-07-08
Granted: 2007-10-18
Abstract: Disclosed herein are constitutively activated, non-endogenous versions of endogenous human G protein-coupled receptors comprising (a) the following amino acid sequence region (C-terminus to N-terminus orientation) and/or (b) the following nucleic acid sequence region (3' to 5' orientation) transversing the transmembrane-6 (TM6) and intracellular loop-3 (IC3) regions of the GPCR: (a) P<SUP>1 </SUP>AA<SUB>15</SUB>X and/or (b) p<SUP>codon </SUP>(AA-codon)<SUB>15 </SUB>X<SUB>codon</SUB>, respectively. In a most preferred embodiment, P<SUP>1 </SUP>and P<SUP>codon </SUP>are endogenous proline and an endogenous nucleic acid encoding region encoding proline, respectively, located within TM6 of the non-endogenous GPCR; AA<SUB>15 </SUB>and (AA-codon)<SUB>15 </SUB>are 15 endogenous amino acid residues and 15 codons encoding endogenous amino acid residues, respectively; and X and X<SUB>codon </SUB>are non-endogenous lysine and a non-endogenous nucleic acid encoding region encoding lysine, respectively, located within IC3 of the non-endogenous GPCR. Because it is most preferred that the non-endogenous human GPCRs which incorporate these mutations are incorporated into mammalian cells and utilized for the screening of candidate compounds, the non-endogenous human GPCR incorporating the mutation need not be purified and isolated per se (i.e., these are incorporated within the cellular membrane of a mammalian cell), although such purified and isolated non-endogenous human GPCRs are well within the purview of this disclosure.
Patent AU-2004220681-B2 (AU)
Title: Soil membrane forming mixture
Inventor: JOHNSEN TORFINN
IPC: A01G13/00
Filed: 2004-03-12
Granted: 2008-05-22
Abstract: This invention relates to an organic, environment-friendly, preferably antioxidising and biodegradable climate, soil and growth enhancing mixture of preferably organic materials that can be applied to moist soil as dry matter or dry soil in liquid state, and which subsequently solidifies into a degradable film or membrane on top of or at a given depth in the soil. The properties of the film can be set so that the film regulates or changes the soil's oxidation ability, degradation rate, temperature, greenhouse gas respiration, combustibility, mechanical strength, evaporation rate, water runoff, nutrient conversion rate and germination conditions on and/or below the surface of the soil mass. The film or membrane can be used alone or in combination with standard plant nutrition or fertiliser.
Patent AU-2004253460-B2 (AU)
Title: Method for treating alcoholic hepatitis
Inventor: YANG RUNKUAN
IPC: A61P1/16
Filed: 2004-06-10
Granted: 2007-09-27
Abstract: Disclosed is a method for treating acute alcoholic hepatitis in a subject. The method comprises the step of administering to the subject an effective amount of an ester of an alpha-ketoalkanoic acid or an amide of an alpha-ketoalkanoic acid.
Patent AU-2004280587-B2 (AU)
Title: Water gun with adjustable force pressure chamber
Inventor: ZIMMERMAN JEFFREY C
IPC: F41B9/00
Filed: 2004-10-05
Granted: 2007-11-29
Abstract: A toy water gun having a water supply tank which can be filled with water, and a water pump located on the housing for pumping water from the supply tank to at least one water pressure chamber. The water pressure chamber includes at least one fixed wall, and a moveable wall which substantially sealingly engages the at least one fixed wall and is slidable away from a first end wall as water is pumped into the water pressure chamber and toward the first end wall as water is discharged. An air pressure chamber located on an opposite side of the moveable wall from the water pressure chamber and is pressurizable with compressed air to bias the moveable wall toward the first end wall. An air pump is connected to the air pressure chamber for pressurizing the air pressure chamber with a user desired air pressure. Upon actuation of the release valve, the air pressure acts on the moveable wall to force water under pressure from the water pressure chamber so that a stream of water is ejected from the nozzle.
Patent AU-2004296804-B2 (AU)
Title: Methods and compositions for autism risk assessment
Inventor: BUXBAUM JOSEPH D
IPC: A61B/
Filed: 2004-12-03
Granted: 2011-04-14
Abstract: Methods and compositions are provided for evaluating an individual for relative genetic risk for autism, for identifying a form of a genetic polymorphism that is linked to autism, and for evaluating whether a compound affects autism.
Patent AU-2005282927-B2 (AU)
Title: Surgical support for femur
Inventor: MATTA JOEL M
IPC: A61B19/00
Filed: 2005-08-31
Granted: 2012-03-01
Abstract: A surgical support for a femur utilizing a shaft having a proximal portion and a distal portion. The shaft lies along an axis which is coincident with a first plane. A hook connects to the shaft through an intermediate portion and lies in a second plane which intersects the first plane. The hook includes a flattened portion for support of the femur.
Patent AU-2006220201-B2 (AU)
Title: Methods and compositions for the detection and analysis of nucleic acids by signal amplification
Inventor: HOANG-ANH HO
IPC: C12Q1/00
Filed: 2006-03-03
Granted: 2011-08-04
Abstract: The present invention relates to a novel integrated PCR-free signal amplification polynucleotide detection system which combines a specific receptor, an optical transducer, and an amplification mechanism. This novel detection system is based on different electrostatic interactions and conformations between a cationic polythiophene (i.e. polymer 1) and single-stranded or double-stranded polynucleotides (such as ss-DNA or ds-DNA), and the efficient energy transfer between the triplex (complexation between the cationic polythiophene and ds-DNA) and neighboring fluorophores attached to ss-DNA or ds-DNA probes. It is to be understood that in the case of ss-DNA, triplex formation occurs via the hybridization of complementary ss-DNA strands, combined with complexation with the cationic polythiophene. The present detection system allows for the detection of single nucleotide polymorphisms (SNPs) from samples in only a few minutes, without the need for nucleic acid amplification.
Patent AU-2006226140-B2 (AU)
Title: Laundry processing apparatus
Inventor: ERIC CLARKE
IPC: B65G47/50
Filed: 2006-03-23
Granted: 2011-08-11
Abstract: The present invention provides laundry processing apparatus (40) for moving laundry receptacles (43) from a first processing station (44) to a second processing station (46), the apparatus having a track (42) for linking the first and second processing stations, wherein a plurality of laundry receptacles can be stored on the track, and means (49, 50) for moving a desired laundry receptacle on the track from the first processing station to the second processing station by moving all of the laundry receptacles along the track.
Patent AU-2006228150-B2 (AU)
Title: Inhibitors of neurotrypsin and determination thereof
Inventor: BEAT KUNZ
IPC: C07C311/47
Filed: 2006-03-29
Granted: 2011-09-29
Abstract: The invention relates to a method for determining whether a compound is a neurotrypsin inhibitor, characterized in that the compound is incubated together with neurotrypsin, a variant thereof or a fragment comprising the protease domain and with a protein or peptide comprising agrin, a variant thereof or a fragment comprising the - or the - cleavage site of agrin, in an aqueous buffer solution, and the amount of cleavage of agrin is measured. Additionally, the invention relates to inhibitors of neurotrypsin found by this method, in particular to compounds of formula (1) wherein Hal and Hal are fluorine, chlorine or bromine, and the use of such inhibitors for the treatment and/or prophylaxis of diseases caused by deficiency of synapses, for example skeletal muscle atrophy, schizophrenia, and cognitive disturbance.
Patent AU-2006244242-B2 (AU)
Title: Resin-soluble thermoplastic veil for composite materials
Inventor: WEBB WILLIAM ERWIN
IPC: C08J5/24
Filed: 2006-05-08
Granted: 2012-07-19
Abstract: A resin-soluble thermoplastic polymer veil toughening element for a curable composition wherein the polymer element is a non-woven veil in solid phase adapted to undergo at least partial phase transition to fluid phase on contact with a component of the curable resin matrix composition in which it is soluble at a temperature which is less than the temperature for substantial onset of gelling and/or curing of the curable composition and which temperature is less than the polymer elements melt temperature; a method for the preparation thereof, a preform support structure for a curable composition comprising the at least one thermoplastic veil element together with structural reinforcement fibers, methods for preparation thereof, a curable composition comprising the at least one thermoplastic veil element or the support structure and a curable resin matrix composition, a method for preparation and curing thereof, and a cured composite or resin body obtained thereby, and known and novel uses thereof.
Patent AU-2006344099-B2 (AU)
Title: Sol-gel nanostructured titania reservoirs for use in the controlled release of drugs in the central nervous system and method of synthesis
Inventor: LOPEZ-GOERNE TESSY MARIA
IPC: A61K9/00
Filed: 2006-06-06
Granted: 2013-02-28
Abstract: The invention is related to a sol-gel nanostructured titania reservoir and its synthesis which is biocompatible with brain tissue. The pore size distribution, crystallite size and the extent of the crystalline phase distribution of anatase, brookite and rutile can be fully controlled. This device may be used to contain neurological drugs. It may be inserted directly into brain tissue for the purpose of the controlled time release of drugs over a period of from 6 months to three years.
Patent AU-2007203745-B2 (AU)
Title: Protein hydrolysates and method of making
Inventor: BLANTON MADISON V
IPC: A23L13/00
Filed: 2007-01-04
Granted: 2011-08-04
Abstract: Methods of making protein hydrolysates are described. The methods may include the steps of providing a solution comprising protein, and adjusting a pH of the solution to about 10.4 or more to form a basic protein solution. Additional steps may include adding a protease enzyme to the basic protein solution that converts at least a portion of the protein to protein hydrolysates. Protein hydrolysate compositions and water-soluble food additives are also described. The additives may include a mixture of protein hydrolysates formed by protein hydrolysis of a protein substrate. The protein hydrolysates may have an average molecular weight of about 2000 to about 10,000 Daltons.